Preclinical and clinical models of lung cancer chemoprevention.
暂无分享,去创建一个
[1] T. Yun,et al. Experimental and epidemiological evidence of the cancer-preventive effects of Panax ginseng C.A. Meyer. , 2009, Nutrition reviews.
[2] L. Dwyer-Nield,et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). , 1998, Carcinogenesis.
[3] V. Steele,et al. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. , 1997, Cancer research.
[4] M. Sporn,et al. Recent advances in chemoprevention of cancer. , 1997, Science.
[5] W. Hong,et al. Retinoids in Head and Neck Chemoprevention , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[6] R. Maronpot,et al. The carcinogenic potential of the gas phase of environmental tobacco smoke. , 1997, Carcinogenesis.
[7] Y. Miller,et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. , 1997, The Journal of clinical investigation.
[8] T. Dragani,et al. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. , 1997, Carcinogenesis.
[9] R. Estensen,et al. Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice. , 1997, Carcinogenesis.
[10] V. Jordan. Tamoxifen: the herald of a new era of preventive therapeutics. , 1997, Journal of the National Cancer Institute.
[11] F. Khuri,et al. Chemoprevention of respiratory tract cancer. , 1997, Hematology/oncology clinics of North America.
[12] A. Castonguay,et al. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. , 1997, Carcinogenesis.
[13] R. Maronpot,et al. The carcinogenicity of environmental tobacco smoke. , 1997, Carcinogenesis.
[14] M. Spitz,et al. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. , 1997, Journal of the National Cancer Institute.
[15] G. Stoner,et al. Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. , 1996, Cancer letters.
[16] R. Estensen,et al. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. , 1996, Cancer research.
[17] M R Cullen,et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.
[18] Stephen Leeder. Scientific Basis of Health Services , 1996, Springer US.
[19] Bin Chen,et al. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas , 1996, Molecular carcinogenesis.
[20] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[21] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[22] C. Galán,et al. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[23] M. King,et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. , 1996, American journal of human genetics.
[24] David B. Holiday,et al. Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. , 1995, The American journal of clinical nutrition.
[25] J. Minna,et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.
[26] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[27] G. Stoner,et al. Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain a mice. , 1995, Cancer letters.
[28] Y. Lee,et al. Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. , 1995, Anticancer research.
[29] J. Yokota,et al. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. , 1994, Cancer research.
[30] S. Amin,et al. Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. , 1994, Cancer research.
[31] A. Galbraith,et al. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. , 1994, Cancer letters.
[32] S. Lippman,et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] V. Steele,et al. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. , 1994, Cancer research.
[34] J. German. Bloom Syndrome: A Mendelian Prototype of Somatic Mutational Disease , 1993, Medicine.
[35] R. Metcalf,et al. p53 protein accumulates frequently in early bronchial neoplasia. , 1993, Cancer research.
[36] R. Estensen,et al. Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. , 1993, Carcinogenesis.
[37] S. Hecht,et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P450. , 1993, Carcinogenesis.
[38] M Buyse,et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A E Profio,et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. , 1993, The Journal of thoracic and cardiovascular surgery.
[40] J. Minna. The molecular biology of lung cancer pathogenesis. , 1993, Chest.
[41] W. Beckett. Epidemiology and etiology of lung cancer. , 1993, Clinics in chest medicine.
[42] M. Humbert,et al. Serum neopterin after lung transplantation. , 1993, Chest.
[43] R. Hermus,et al. Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. , 1992, British Journal of Cancer.
[44] A. Conney,et al. Inhibitory effect of green tea on the growth of established skin papillomas in mice. , 1992, Cancer research.
[45] R. Hoover,et al. The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype. , 1992, Environmental health perspectives.
[46] U. Pastorino,et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.
[47] A. Castonguay,et al. Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. , 1992, Cancer letters.
[48] S. Amin,et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. , 1992, Chemical research in toxicology.
[49] S. Amin,et al. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. , 1992, Cancer research.
[50] S. Shi,et al. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. , 1992, Carcinogenesis.
[51] Y. Lee,et al. Inhibitory effects of biochanin A on benzo(a)pyrene induced carcinogenesis in mice. , 1992, In vivo.
[52] A. Malkinson. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. , 1992, Cancer research.
[53] L. Booker,et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. , 1992, British Journal of Cancer.
[54] Jun-yan Hong,et al. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. , 1992, Cancer research.
[55] T. Pechacek,et al. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.
[56] G E Moore,et al. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. , 1991, Cancer research.
[57] S. Amin,et al. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. , 1991, Cancer research.
[58] G. Stoner,et al. Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. , 1991, Experimental lung research.
[59] J. Minna,et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.
[60] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[61] K. Toyoda,et al. Inhibitory Effects of Antioxidants on N‐Bis(2‐hydroxypropyl)nitrosamine‐induced Lung Carcinogenesis in Rats , 1990, Japanese journal of cancer research : Gann.
[62] T. Sellers,et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. , 1990, Journal of the National Cancer Institute.
[63] S. Amin,et al. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. , 1990, Cancer research.
[64] R. Hoover,et al. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. , 1990, Cancer research.
[65] H. Mukhtar,et al. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. , 1989, Cancer research.
[66] S. Amin,et al. Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. , 1989, Carcinogenesis.
[67] G. Draper,et al. Non-ocular cancer in relatives of retinoblastoma patients. , 1989, British Journal of Cancer.
[68] S. Amin,et al. Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. , 1989, Cancer research.
[69] Marshall W. Anderson,et al. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[70] A. Malkinson. The genetic basis of susceptibility to lung tumors in mice. , 1989, Toxicology.
[71] S. Rodenhuis,et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.
[72] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[73] D. Heimburger,et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. , 1988, JAMA.
[74] T. Sellers,et al. Increased familial risk for non-lung cancer among relatives of lung cancer patients. , 1987, American journal of epidemiology.
[75] L. Wattenberg. Protective effects of 2(3)-tert-butyl-4-hydroxyanisole on chemical carcinogenesis. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[76] W. Kimberling,et al. Genetics and smoking‐associated cancers. A study of 485 families , 1986, Cancer.
[77] J. Fielding. Smoking: Health Effects and Control , 1985 .
[78] K. Weiss,et al. Cancer mortality in relatives of retinoblastoma patients. , 1984, Journal of the National Cancer Institute.
[79] W. Willett,et al. Diet and cancer--an overview. , 1984, The New England journal of medicine.
[80] P. Lesca. Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. , 1983, Carcinogenesis.
[81] A. Verma,et al. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. , 1983, Cancer research.
[82] J. Mulvihill,et al. Familial respiratory tract cancer. Opportunities for research and prevention. , 1982, JAMA.
[83] L. Wattenberg. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by sodium cyanate. , 1980, Cancer research.
[84] S. Belman,et al. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. , 1972, Cancer research.
[85] L. Wattenberg,et al. Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. , 1970, Cancer research.
[86] A. Lilienfeld,et al. Familial aggregation of lung cancer in humans. , 1963, Journal of the National Cancer Institute.
[87] R. Doll,et al. A study of the aetiology of carcinoma of the lung. , 1953, Pakistan journal of health.
[88] K. Svenson,et al. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. , 1998, Experimental lung research.
[89] J. Siegfried. Biology and chemoprevention of lung cancer. , 1998, Chest.
[90] M. You,et al. Chemopreventive effect of perillyl alcohol on 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung , 1997, Journal of cellular biochemistry. Supplement.
[91] M. You,et al. Genetic alterations in mouse lung tumors: Implications for cancer chemoprevention , 1997, Journal of cellular biochemistry. Supplement.
[92] C. Boone,et al. Biomarker end-points in cancer chemoprevention trials. , 1997, IARC scientific publications.
[93] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[94] J. Minna,et al. Molecular genetic changes found in human lung cancer and its precursor lesions. , 1994, Cold Spring Harbor symposia on quantitative biology.
[95] M. Boukharta,et al. Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. , 1992, Nutrition and cancer.
[96] H. McDuffie,et al. Clustering of cancer in families of patients with primary lung cancer. , 1991, Journal of clinical epidemiology.
[97] T J Mason,et al. Lung cancer risk associated with cancer in relatives. , 1991, Journal of clinical epidemiology.
[98] L. Wattenberg,et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. , 1991, Carcinogenesis.
[99] L. Wattenberg. Chemoprevention of cancer. , 1985, Cancer research.
[100] D. Brian,et al. Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin. , 1982, Acta cytologica.
[101] J. Misset,et al. Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. , 1982, Cancer detection and prevention.